Cellular Dynamics International (ICEL) 5.27 $ICEL
Cellular Dynamics' iCell Hepatocytes Enable Malaria-in-a-Dish Studies
GlobeNewswire - Wed Feb 11, 9:55AM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced that its iCell(R) Hepatocytes, or human liver cells manufactured from induced pluripotent stem cells (iPSCs), have been used as a malaria-in-a-dish model to test anti-malarial drug candidates. Sangeeta N. Bhatia, M.D., Ph.D., of the Institute for Medical Engineering and Science, Massachusetts Institute of Technology, infected the iPSC-derived hepatocytes with parasitic Plasmodium species, characterized the cells' drug metabolism capabilities using known antimalarial drugs, and chemically matured the cells to demonstrate higher sensitivity to a different class of drugs. The study was published in Stem Cell Reports.
ICEL: 5.27 (+0.02)
Cellular Dynamics Manufactures cGMP HLA 'Superdonor' Stem Cell Lines to Enable Cell Therapy with Genetic Matching
PRWeb - Mon Feb 09, 8:07AM CST
Cellular Dynamics International, Inc. (CDI; Nasdaq: ICEL) today announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA "superdonors." HLA superdonors are individuals whose genetic HLA (human leukocyte antigens, or HLA) profiles make their cells or tissues more compatible for donation to unrelated patients--a concern that arises with organ or tissue transplantation and potential rejection. As the first announced HLA superdonor master cell bank in the world, and the first produced under cGMP, these cell lines will enable a new area of cell therapy research using HLA matching.
ICEL: 5.27 (+0.02)
Cellular Dynamics Manufactures cGMP HLA "Superdonor" Stem Cell Lines to Enable Cell Therapy With Genetic Matching
GlobeNewswire - Mon Feb 09, 7:06AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA "superdonors." HLA superdonors are individuals whose genetic HLA (human leukocyte antigens, or HLA) profiles make their cells or tissues more compatible for donation to unrelated patients--a concern that arises with organ or tissue transplantation and potential rejection. As the first announced HLA superdonor master cell bank in the world, and the first produced under cGMP, these cell lines will enable a new area of cell therapy research using HLA matching.
ICEL: 5.27 (+0.02)
Cellular Dynamics to Present at Leerink Global Healthcare Conference
GlobeNewswire - Tue Feb 03, 5:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink Global Healthcare Conference held February 11-12, 2015, in New York City.
ICEL: 5.27 (+0.02)
Cellular Dynamics International (ICEL) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:11AM CST
Cellular Dynamics International, Inc. (ICEL) was a big mover last session, as the company saw its shares rise over 8% on the day.
ICEL: 5.27 (+0.02), PAHC: 30.85 (+0.36)
Nasdaq stocks posting largest percentage increases
AP - Thu Jan 29, 12:23PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
UIHC: 27.40 (-0.34), ABMD: 60.39 (+0.46), ACAT: 39.00 (+1.31), CSII: 35.69 (+0.17), EA: 56.39 (+0.20), NVC.TO: 11.27 (-0.23), ARKR: 24.52 (-0.04), OMER: 20.63 (+0.13), RESN: 16.62 (-1.38), ICEL: 5.27 (+0.02), ANIP: 62.69 (-0.43), JST: 5.35 (+0.14), ADVS: 44.18 (+0.20), AAPL: 127.08 (+0.62), NVCN: 9.08 (-0.17)
Cord Blood Registry and Cellular Dynamics International Announce Collaboration to Reprogram Newborn Stem Cells into Induced Pluripotent Stem Cells
PR Newswire - Tue Jan 13, 8:02AM CST
Cord Blood Registry® (CBR®) and Cellular Dynamics International (NASDAQ: ICEL) (CDI) announced today that they have entered into a research collaboration to reprogram newborn stem cells from both umbilical cord blood and umbilical cord tissue collected, processed and cryopreserved under CBR's protocols into induced pluripotent stem cells (iPSCs) using CDI's proprietary methods.
ICEL: 5.27 (+0.02)
Cellular Dynamics to Present at 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Thu Jan 08, 5:36PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 33 Annual J.P. Morgan Healthcare Conference in San Francisco from January 12-15, 2015.
ICEL: 5.27 (+0.02), JPM: 59.67 (+0.10)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 11:45AM CST
SD: 2.09 (+0.14), FRO: 2.96 (+0.07), EXXI: 4.00 (+0.42), HGG: 6.78 (+0.34), QADA: 20.36 (+0.14), CBMX: 1.83 (-0.16), CHOP: 0.87 (-0.01), CLDN: 16.45 (-0.05), MOC: 2.24 (+0.02), NDRM: 10.76 (+0.22), CALI: 1.35 (+0.06), GDP: 3.58 (+0.29), TNXP: 5.78 (-0.02), ICEL: 5.27 (+0.02), NERV: 4.68 (+0.09), CYTR: 2.96 (+0.23), BBLU: 1.26 (+0.09), ATHX: 2.12 (unch), PEIX: 9.82 (+0.15), PGN: 2.88 (-0.07)
Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST
TTPH: 35.18 (-0.73), ZSPH: 46.77 (+3.42), AMRN: 1.18 (unch), OPHT: 51.11 (+0.12), AERI: 27.91 (+0.14), ASPX: 65.76 (+2.76), CNCE: 12.76 (-0.46), ICEL: 5.27 (+0.02), GWPH: 78.09 (+1.70), AUXL: 36.47 (-0.06), RTRX: 13.92 (+0.44), RCPT: 115.83 (-0.66), AAVL: 36.29 (+0.01), AKBA: 9.32 (+0.51), EXPR: 14.61 (+0.33), RARE: 54.10 (+0.12), RLYP: 33.98 (+0.60), PETX: 16.52 (-0.10), ENTA: 33.30 (-0.44), RDUS: 50.37 (+0.63), CARA: 10.96 (-0.03), FLML: 14.15 (+0.15), ALIM: 5.16 (unch), ANIP: 62.69 (-0.43), ICPT: 209.12 (+7.12), RVNC: 16.84 (+0.27), POZN: 6.95 (+0.15), FPRX: 24.63 (+0.63), ZFGN: 39.06 (+0.92), CRIS: 3.23 (+0.25), QLTI: 4.15 (unch), PCYC: 163.28 (+0.23), PTX: 8.63 (+0.01), CLDN: 16.45 (-0.05), RIGL: 2.47 (+0.05), HPTX: 26.83 (-0.05), AMPH: 12.76 (+0.02), INO: 6.80 (-0.15), VSAR: 18.04 (-0.55), FMI: 48.88 (+0.17), TBPH: 18.51 (+0.28), XLRN: 38.02 (+0.07), MGNX: 34.09 (+0.10), INSM: 17.40 (+0.69), ONTX: 2.27 (-0.02), ALDR: 26.06 (+0.18), SAGE: 41.03 (-0.07), KITE: 62.59 (+0.82), CGEN: 8.19 (+0.08), FOLD: 8.36 (-0.11), KPTI: 27.12 (-0.13)
Cellular Dynamics set for gap down at the open
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 8:07AM CST
ICEL: 5.27 (+0.02)
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 35.18 (-0.73), ZSPH: 46.77 (+3.42), AMRN: 1.18 (unch), OPHT: 51.11 (+0.12), AERI: 27.91 (+0.14), ASPX: 65.76 (+2.76), CNCE: 12.76 (-0.46), ICEL: 5.27 (+0.02), GWPH: 78.09 (+1.70), AUXL: 36.47 (-0.06), RTRX: 13.92 (+0.44), RCPT: 115.83 (-0.66), AAVL: 36.29 (+0.01), AKBA: 9.32 (+0.51), EXPR: 14.61 (+0.33), RARE: 54.10 (+0.12), ZGNX: 1.43 (+0.05), RLYP: 33.98 (+0.60), PETX: 16.52 (-0.10), ENTA: 33.30 (-0.44), RDUS: 50.37 (+0.63), CARA: 10.96 (-0.03), FLML: 14.15 (+0.15), ALIM: 5.16 (unch), ANIP: 62.69 (-0.43), ICPT: 209.12 (+7.12), RVNC: 16.84 (+0.27), POZN: 6.95 (+0.15), NDAQ: 49.48 (-0.27), FPRX: 24.63 (+0.63), CRIS: 3.23 (+0.25), ZFGN: 39.06 (+0.92), QLTI: 4.15 (unch), PCYC: 163.28 (+0.23), PTX: 8.63 (+0.01), CLDN: 16.45 (-0.05), RIGL: 2.47 (+0.05), HPTX: 26.83 (-0.05), AMPH: 12.76 (+0.02), INO: 6.80 (-0.15), VSAR: 18.04 (-0.55), FMI: 48.88 (+0.17), TBPH: 18.51 (+0.28), XLRN: 38.02 (+0.07), MGNX: 34.09 (+0.10), INSM: 17.40 (+0.69), ONTX: 2.27 (-0.02), ALDR: 26.06 (+0.18), SAGE: 41.03 (-0.07), KITE: 62.59 (+0.82), CGEN: 8.19 (+0.08), FOLD: 8.36 (-0.11), KPTI: 27.12 (-0.13)
Cellular Dynamics to Present at the Piper Jaffray 26th Annual Healthcare Conference
GlobeNewswire - Mon Dec 01, 11:39AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Operating Officer Emile Nuwaysir will participate in the Piper Jaffray 26 Annual Healthcare Conference to be held December 2-3 in New York City.
ICEL: 5.27 (+0.02)
Cellular Dynamics and Northwestern University Take First Steps Toward Rebuilding an Organ Using Manufactured Human Cells
GlobeNewswire - Tue Nov 18, 7:40AM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced the publication of a study in the American Journal of Transplantation describing a key first step in ultimately rebuilding and eventually transplanting organs: recreating a portion of the blood supply infrastructure. Jason Wertheim, M.D., Ph.D., Assistant Professor of Surgery-Organ Transplantation at Northwestern University Feinberg School of Medicine, used CDI's iCell(R) Endothelial Cells to coat the blood supply system of a kidney scaffold, which is crucial for circulation and nutrient distribution throughout the tissue of any organ. This is a key first step in repairing or regenerating organs for transplant.
ICEL: 5.27 (+0.02)
Cellular Dynamics International names Susan A. Willetts to board
M2 - Thu Nov 13, 5:55AM CST
Human cells company Cellular Dynamics International (NasdaqGM:ICEL) revealed on Wednesday that Susan A. Willetts has joined its board of directors and its audit committee, effective 6 November 2014.
ICEL: 5.27 (+0.02)
Susan A. Willetts Joins Cellular Dynamics' Board of Directors
GlobeNewswire - Wed Nov 12, 2:12PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Susan A. Willetts was elected to the company's board of directors, effective November 6, 2014. Ms. Willetts also will serve as a member of the CDI board's audit committee.
ICEL: 5.27 (+0.02)
Cellular Dynamics net loss improves in Q3
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:28AM CST
ICEL: 5.27 (+0.02)
Cellular Dynamics International's (ICEL) CEO Bob Palay on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 11, 10:44AM CST
ICEL: 5.27 (+0.02)
Cellular Dynamics' iCell Hepatocytes Enable Malaria-in-a-Dish Studies
GlobeNewswire - Wed Feb 11, 9:55AM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced that its iCell(R) Hepatocytes, or human liver cells manufactured from induced pluripotent stem cells (iPSCs), have been used as a malaria-in-a-dish model to test anti-malarial drug candidates. Sangeeta N. Bhatia, M.D., Ph.D., of the Institute for Medical Engineering and Science, Massachusetts Institute of Technology, infected the iPSC-derived hepatocytes with parasitic Plasmodium species, characterized the cells' drug metabolism capabilities using known antimalarial drugs, and chemically matured the cells to demonstrate higher sensitivity to a different class of drugs. The study was published in Stem Cell Reports.
ICEL: 5.27 (+0.02)
Cellular Dynamics Manufactures cGMP HLA 'Superdonor' Stem Cell Lines to Enable Cell Therapy with Genetic Matching
PRWeb - Mon Feb 09, 8:07AM CST
Cellular Dynamics International, Inc. (CDI; Nasdaq: ICEL) today announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA "superdonors." HLA superdonors are individuals whose genetic HLA (human leukocyte antigens, or HLA) profiles make their cells or tissues more compatible for donation to unrelated patients--a concern that arises with organ or tissue transplantation and potential rejection. As the first announced HLA superdonor master cell bank in the world, and the first produced under cGMP, these cell lines will enable a new area of cell therapy research using HLA matching.
ICEL: 5.27 (+0.02)
Cellular Dynamics Manufactures cGMP HLA "Superdonor" Stem Cell Lines to Enable Cell Therapy With Genetic Matching
GlobeNewswire - Mon Feb 09, 7:06AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA "superdonors." HLA superdonors are individuals whose genetic HLA (human leukocyte antigens, or HLA) profiles make their cells or tissues more compatible for donation to unrelated patients--a concern that arises with organ or tissue transplantation and potential rejection. As the first announced HLA superdonor master cell bank in the world, and the first produced under cGMP, these cell lines will enable a new area of cell therapy research using HLA matching.
ICEL: 5.27 (+0.02)
Cellular Dynamics to Present at Leerink Global Healthcare Conference
GlobeNewswire - Tue Feb 03, 5:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink Global Healthcare Conference held February 11-12, 2015, in New York City.
ICEL: 5.27 (+0.02)
Cellular Dynamics International (ICEL) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:11AM CST
Cellular Dynamics International, Inc. (ICEL) was a big mover last session, as the company saw its shares rise over 8% on the day.
ICEL: 5.27 (+0.02), PAHC: 30.85 (+0.36)
Nasdaq stocks posting largest percentage increases
AP - Thu Jan 29, 12:23PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
UIHC: 27.40 (-0.34), ABMD: 60.39 (+0.46), ACAT: 39.00 (+1.31), CSII: 35.69 (+0.17), EA: 56.39 (+0.20), NVC.TO: 11.27 (-0.23), ARKR: 24.52 (-0.04), OMER: 20.63 (+0.13), RESN: 16.62 (-1.38), ICEL: 5.27 (+0.02), ANIP: 62.69 (-0.43), JST: 5.35 (+0.14), ADVS: 44.18 (+0.20), AAPL: 127.08 (+0.62), NVCN: 9.08 (-0.17)
Cord Blood Registry and Cellular Dynamics International Announce Collaboration to Reprogram Newborn Stem Cells into Induced Pluripotent Stem Cells
PR Newswire - Tue Jan 13, 8:02AM CST
Cord Blood Registry® (CBR®) and Cellular Dynamics International (NASDAQ: ICEL) (CDI) announced today that they have entered into a research collaboration to reprogram newborn stem cells from both umbilical cord blood and umbilical cord tissue collected, processed and cryopreserved under CBR's protocols into induced pluripotent stem cells (iPSCs) using CDI's proprietary methods.
ICEL: 5.27 (+0.02)
Cellular Dynamics to Present at 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Thu Jan 08, 5:36PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 33 Annual J.P. Morgan Healthcare Conference in San Francisco from January 12-15, 2015.
ICEL: 5.27 (+0.02), JPM: 59.67 (+0.10)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 11:45AM CST
SD: 2.09 (+0.14), FRO: 2.96 (+0.07), EXXI: 4.00 (+0.42), HGG: 6.78 (+0.34), QADA: 20.36 (+0.14), CBMX: 1.83 (-0.16), CHOP: 0.87 (-0.01), CLDN: 16.45 (-0.05), MOC: 2.24 (+0.02), NDRM: 10.76 (+0.22), CALI: 1.35 (+0.06), GDP: 3.58 (+0.29), TNXP: 5.78 (-0.02), ICEL: 5.27 (+0.02), NERV: 4.68 (+0.09), CYTR: 2.96 (+0.23), BBLU: 1.26 (+0.09), ATHX: 2.12 (unch), PEIX: 9.82 (+0.15), PGN: 2.88 (-0.07)
Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST
TTPH: 35.18 (-0.73), ZSPH: 46.77 (+3.42), AMRN: 1.18 (unch), OPHT: 51.11 (+0.12), AERI: 27.91 (+0.14), ASPX: 65.76 (+2.76), CNCE: 12.76 (-0.46), ICEL: 5.27 (+0.02), GWPH: 78.09 (+1.70), AUXL: 36.47 (-0.06), RTRX: 13.92 (+0.44), RCPT: 115.83 (-0.66), AAVL: 36.29 (+0.01), AKBA: 9.32 (+0.51), EXPR: 14.61 (+0.33), RARE: 54.10 (+0.12), RLYP: 33.98 (+0.60), PETX: 16.52 (-0.10), ENTA: 33.30 (-0.44), RDUS: 50.37 (+0.63), CARA: 10.96 (-0.03), FLML: 14.15 (+0.15), ALIM: 5.16 (unch), ANIP: 62.69 (-0.43), ICPT: 209.12 (+7.12), RVNC: 16.84 (+0.27), POZN: 6.95 (+0.15), FPRX: 24.63 (+0.63), ZFGN: 39.06 (+0.92), CRIS: 3.23 (+0.25), QLTI: 4.15 (unch), PCYC: 163.28 (+0.23), PTX: 8.63 (+0.01), CLDN: 16.45 (-0.05), RIGL: 2.47 (+0.05), HPTX: 26.83 (-0.05), AMPH: 12.76 (+0.02), INO: 6.80 (-0.15), VSAR: 18.04 (-0.55), FMI: 48.88 (+0.17), TBPH: 18.51 (+0.28), XLRN: 38.02 (+0.07), MGNX: 34.09 (+0.10), INSM: 17.40 (+0.69), ONTX: 2.27 (-0.02), ALDR: 26.06 (+0.18), SAGE: 41.03 (-0.07), KITE: 62.59 (+0.82), CGEN: 8.19 (+0.08), FOLD: 8.36 (-0.11), KPTI: 27.12 (-0.13)
Cellular Dynamics set for gap down at the open
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 8:07AM CST
ICEL: 5.27 (+0.02)
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 35.18 (-0.73), ZSPH: 46.77 (+3.42), AMRN: 1.18 (unch), OPHT: 51.11 (+0.12), AERI: 27.91 (+0.14), ASPX: 65.76 (+2.76), CNCE: 12.76 (-0.46), ICEL: 5.27 (+0.02), GWPH: 78.09 (+1.70), AUXL: 36.47 (-0.06), RTRX: 13.92 (+0.44), RCPT: 115.83 (-0.66), AAVL: 36.29 (+0.01), AKBA: 9.32 (+0.51), EXPR: 14.61 (+0.33), RARE: 54.10 (+0.12), ZGNX: 1.43 (+0.05), RLYP: 33.98 (+0.60), PETX: 16.52 (-0.10), ENTA: 33.30 (-0.44), RDUS: 50.37 (+0.63), CARA: 10.96 (-0.03), FLML: 14.15 (+0.15), ALIM: 5.16 (unch), ANIP: 62.69 (-0.43), ICPT: 209.12 (+7.12), RVNC: 16.84 (+0.27), POZN: 6.95 (+0.15), NDAQ: 49.48 (-0.27), FPRX: 24.63 (+0.63), CRIS: 3.23 (+0.25), ZFGN: 39.06 (+0.92), QLTI: 4.15 (unch), PCYC: 163.28 (+0.23), PTX: 8.63 (+0.01), CLDN: 16.45 (-0.05), RIGL: 2.47 (+0.05), HPTX: 26.83 (-0.05), AMPH: 12.76 (+0.02), INO: 6.80 (-0.15), VSAR: 18.04 (-0.55), FMI: 48.88 (+0.17), TBPH: 18.51 (+0.28), XLRN: 38.02 (+0.07), MGNX: 34.09 (+0.10), INSM: 17.40 (+0.69), ONTX: 2.27 (-0.02), ALDR: 26.06 (+0.18), SAGE: 41.03 (-0.07), KITE: 62.59 (+0.82), CGEN: 8.19 (+0.08), FOLD: 8.36 (-0.11), KPTI: 27.12 (-0.13)
Cellular Dynamics to Present at the Piper Jaffray 26th Annual Healthcare Conference
GlobeNewswire - Mon Dec 01, 11:39AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Operating Officer Emile Nuwaysir will participate in the Piper Jaffray 26 Annual Healthcare Conference to be held December 2-3 in New York City.
ICEL: 5.27 (+0.02)
Cellular Dynamics and Northwestern University Take First Steps Toward Rebuilding an Organ Using Manufactured Human Cells
GlobeNewswire - Tue Nov 18, 7:40AM CST
Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced the publication of a study in the American Journal of Transplantation describing a key first step in ultimately rebuilding and eventually transplanting organs: recreating a portion of the blood supply infrastructure. Jason Wertheim, M.D., Ph.D., Assistant Professor of Surgery-Organ Transplantation at Northwestern University Feinberg School of Medicine, used CDI's iCell(R) Endothelial Cells to coat the blood supply system of a kidney scaffold, which is crucial for circulation and nutrient distribution throughout the tissue of any organ. This is a key first step in repairing or regenerating organs for transplant.
ICEL: 5.27 (+0.02)
Cellular Dynamics International names Susan A. Willetts to board
M2 - Thu Nov 13, 5:55AM CST
Human cells company Cellular Dynamics International (NasdaqGM:ICEL) revealed on Wednesday that Susan A. Willetts has joined its board of directors and its audit committee, effective 6 November 2014.
ICEL: 5.27 (+0.02)
Susan A. Willetts Joins Cellular Dynamics' Board of Directors
GlobeNewswire - Wed Nov 12, 2:12PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Susan A. Willetts was elected to the company's board of directors, effective November 6, 2014. Ms. Willetts also will serve as a member of the CDI board's audit committee.
ICEL: 5.27 (+0.02)
Cellular Dynamics net loss improves in Q3
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:28AM CST
ICEL: 5.27 (+0.02)
Cellular Dynamics International's (ICEL) CEO Bob Palay on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 11, 10:44AM CST
ICEL: 5.27 (+0.02)
